STOCK TITAN

TaoWeave (Nasdaq: OBLG) makes $1M Manako Physical AI partnership move

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

TaoWeave, Inc. entered a Technology License and Distribution Agreement with Manako Labs to commercialize Manako’s Score AI computer vision platform in the United States and Canada. This partnership combines Manako’s Physical AI technology with TaoWeave’s North American enterprise relationships and public company platform.

Alongside the agreement, TaoWeave invested $1,000,000 in Manako through a Simple Agreement for Future Equity and issued Manako warrants to purchase up to 300,000 TaoWeave common shares at tiered exercise prices. TaoWeave will share in revenue from licensed customers and receive referral and market development fees, while Manako receives revenue share and equity-linked upside. The deal represents TaoWeave’s first operating AI investment and expands its strategy beyond digital asset treasury activities into AI deployment and recurring operating revenue.

Positive

  • None.

Negative

  • None.

Insights

TaoWeave makes its first operating AI investment with revenue sharing and equity-linked terms.

TaoWeave is shifting from a pure digital-asset focus toward operating AI businesses by investing $1,000,000 in Manako Labs via a SAFE and securing North American rights to commercialize Manako’s Physical AI platform. Revenue sharing, referral fees, and market development fees tie TaoWeave’s upside directly to customer adoption.

The warrants for up to 300,000 shares at exercise prices of $3.41, $4.50, and $5.50, together with a 9.99% beneficial ownership cap and structured lock-up, align Manako’s incentives while pacing potential equity overhang. Registration rights within 180 days add liquidity planning without immediate public issuance.

Press release language emphasizes Physical AI’s large addressable market, citing industry research estimating $82 billion size in 2025 and potential to approach $1 trillion by 2033. Actual financial impact will depend on TaoWeave’s execution in winning North American enterprise customers and on Manako’s continued technology and network positioning within the Bittensor ecosystem.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Manako SAFE investment $1,000,000 Equity investment via Simple Agreement for Future Equity
Closing Warrants 100,000 shares at $3.41/share Warrants issued upon Commercial Commencement Date
Tranche A Warrants 100,000 shares at $4.50/share Issuable upon satisfaction of specified conditions
Tranche B Warrants 100,000 shares at $5.50/share Issuable upon achievement of defined milestones
Beneficial ownership limit 9.99% Maximum post‑exercise ownership allowed for Manako and affiliates
Registration deadline 180 days Time from Effective Date to file Warrant Share resale registration
Lock-up and restriction period 6 months + 24 months Initial lock‑up followed by post‑lock‑up trading restrictions
Physical AI market size $82 billion (2025) to ~$1 trillion (2033) Industry research estimates cited in press release
Technology License and Distribution Agreement financial
"TaoWeave, Inc. entered into a Technology License and Distribution Agreement with Manako Labs Ltd"
Simple Agreement for Future Equity financial
"the parties entered into a Simple Agreement for Future Equity (the “SAFE”)"
A simple agreement for future equity is an investment contract that gives an investor the right to receive company shares at a later financing event or sale instead of getting shares immediately. Think of it like a voucher that converts into ownership once the company’s value is formally set; it matters to investors because it fixes how and when ownership is awarded, affects how much of the company they ultimately own, and influences dilution and return potential.
Physical AI technical
"entry into the emerging Physical AI market through an investment in Manako Labs Ltd."
Physical AI combines artificial intelligence with physical devices or environments, enabling machines to interact with and adapt to the real world in a human-like way. It matters to investors because it can lead to smarter robots, autonomous vehicles, or advanced sensors that improve efficiency and open new markets, potentially creating significant business opportunities and competitive advantages.
beneficial ownership limitation regulatory
"Manako may not exercise any portion of such Warrants to the extent that they... would beneficially own more than 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Rule 10b5-1 plan regulatory
"sales pursuant to a Rule 10b5-1 plan established outside a blackout period"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Regulation FD regulatory
"the furnishing of information under Item 7.01... is not intended to constitute a determination... required by Regulation FD"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000746210 0000746210 2026-05-28 2026-05-28
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 28, 2026
 
TAOWEAVE, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of
Incorporation or organization)
001-35376
(Commission File Number)
77-0312442
(IRS Employer
Identification No.)
 
110 16th Street, Suite 1400 - 1024
Denver, Colorado 80202
(Address of principal executive offices, zip code)
 
 
(213) 683-8863 ext. 5
(Registrant’s telephone number, including area code)
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a‑12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
 
TWAV
 
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
1.01: Entry into a Material Definitive Agreement
 
Technology License and Distribution Agreement
 
On May 28, 2026 (the “Effective Date”), TaoWeave, Inc. (the “Company”) entered into a Technology License and Distribution Agreement (the “TLDA”) with Manako Labs Ltd, a company organized under the laws of England and Wales (“Manako”). The TLDA establishes an integration partnership combining Manako’s Score AI computer vision platform operating on Bittensor Subnet 44 and related technologies (the “Platform”) with the Company’s North American enterprise relationships, commercial infrastructure, and public market credibility. 
 
Concurrently with the execution of the TLDA, the parties entered into a Simple Agreement for Future Equity (the “SAFE”) pursuant to which the Company will make an equity investment of $1,000,000 in Manako. The commercial obligations of the parties under the TLDA become operative upon the Company’s payment of the full SAFE investment amount (the “Commercial Commencement Date”). On May 29, 2026, the Company paid in full the SAFE investment amount.
 
The TLDA has an initial term of one (1) year from the Effective Date (the “Initial Term”), with automatic renewal for successive twelve (12) month periods (each, a “Renewal Term” and collectively with the Initial Term, the “License Term”) unless either party provides written notice of non-renewal at least sixty (60) days prior to expiration of the then-current term. Either party may terminate for material breach upon thirty (30) days’ written notice and failure to cure, or upon insolvency of the other party. Either party may terminate for convenience upon ninety (90) days’ prior written notice. If a Subnet Disruption Event (as defined in the TLDA) continues for more than twenty (20) consecutive days, the Company may terminate the TLDA immediately upon written notice. During any Subnet Disruption Event, Manako’s platform availability obligations and the Company’s revenue share payment obligations are suspended. Upon termination, the Company retains the right to continue performing under all customer agreements in effect as of the termination date through the full remaining term of each such agreement (including renewals exercised by the customer), subject to a maximum of twenty-four (24) months. The Company also receives a twelve (12) month transition period following termination. Following expiration or termination (other than termination by Manako for cause pursuant to the terms of the TLDA), the Company will retain a right of first refusal on new business opportunities in the Territory (as defined below) for a period of time to be determined based upon cumulative net revenue.
 
Pursuant to the TLDA, Manako has agreed to grant the Company a non-exclusive, non-transferable, sublicensable license during the License Term to (i) use, copy, and display the Platform and related documentation to customers in the United States and Canada (the “Territory”) solely for purposes of marketing, demonstrating, selling, and distributing the Platform to customers, (ii) permit customers in the Territory to access and use the Platform, and (iii) use Manako’s trademarks in the Territory in connection with the marketing and distribution of the Platform. The Company has the right to sublicense access to the Platform to customers pursuant to customer agreements that contain terms at least as protective of Manako’s intellectual property as those in the TLDA.
 
Pursuant to the TLDA, and in consideration of the licenses and rights granted by Manako, the Company must pay Manako a portion of net revenue received from Platform customers in the Territory that the Company has entered into an agreement with. Where Manako enters into a direct customer agreement with a Territory customer sourced by the Company, previously identified as a Company named account, or closed with the Company’s material involvement, Manako will pay the Company a referral fee based on customer contract value. Where Manako sources, leads, and closes a business opportunity in the Territory directly without the Company’s material involvement (subject to certain exclusions), Manako will pay the Company a market development fee based on customer contract value.
 
In further consideration of the licenses and rights granted by Manako under the TLDA, upon the Commercial Commencement Date, the Company will issue to Manako warrants to purchase up to 100,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at an exercise price of $3.41 per share (the “Closing Warrants”).
 
In connection with potential joint development of the Company’s own subnet on the Bittensor network, the Company may issue additional warrants to Manako as follows: (i) warrants to purchase up to 100,000 shares of Common Stock at an exercise price of $4.50 per share, issuable upon the satisfaction of certain conditions (“Tranche A Warrants”), and (ii) warrants to purchase up to 100,000 shares of Common Stock at an exercise price of $5.50 per share, issuable upon the achievement of certain milestones (“Tranche B Warrants” and together with the Closing Warrants and Tranche A Warrants, the “Warrants”).
 
The exercise price of each Warrant is subject to customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like and dilutive issuances (in each case, subject to certain exceptions). There is no established public trading market for the Warrants and the Company does not intend to list the Warrants on any national securities exchange or nationally recognized trading system.
 
Manako may not exercise any portion of such Warrants to the extent that they, together with any affiliates, would beneficially own more than 9.99%  of the Company’s outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company,  Manako may increase or decrease the beneficial ownership limitation, subject to a maximum of up to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise.
 
The Warrants and the shares of Common Stock underlying the Warrants (the “Warrant Shares”) have not been registered under the Securities Act. Pursuant to the TLDA, the Company, within 180 days of the Effective Date, must file a registration statement for the resale of the Warrant Shares. The Company must use commercially reasonable efforts to cause such registration statement to become effective as soon as practicable thereafter and to keep such registration statement effective at all times until no Warrants or Warrants Shares are outstanding.
 
The TLDA contains certain indemnification provisions, product warranty provisions, confidentiality obligations, insurance requirements, non-compete restrictions, and other miscellaneous terms. The TLDA also contains certain representations, warranties and covenants customary for similar transactions. The representations, warranties and covenants contained in the TLDA were made solely for the benefit of the parties to the TLDA and may be subject to limitations agreed upon by the parties.
 
1

 
Lock-Up Agreement
 
In connection with the TLDA, on May 28, 2026, the Company and Manako entered into a Lock-Up Agreement (the “Lock-Up Agreement”), pursuant to which the Warrants are subject to a lock-up period of six (6) months following issuance or until effective registration of Warrant Shares, whichever is later, followed by twenty-four (24) months of post-lock-up trading restrictions including a daily volume cap of ten percent (10%) of average daily trading volume, a price floor of one hundred twenty percent (120%) of the relevant exercise price, and three (3) trading days’ advance notice of sales. The Lock-Up Agreement provides carve-outs from the post-lock-up trading restrictions for (i) block trades to institutional investors through a registered broker-dealer, (ii) private transfers to Manako affiliates bound by the same obligations, (iii) transfers in connection with any merger, tender offer, or similar transaction involving the Company as issuer, and (iv) sales pursuant to a Rule 10b5-1 plan established outside a blackout period.
 
Simple Agreement for Future Equity
 
In connection with the TLDA, on May 28, 2026, the Company and Manako entered into the SAFE, pursuant to which the Company will invest $1,000,000 (the “SAFE Amount”) in Manako.
 
Pursuant to the SAFE, if Manako consummates a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which Manako issues and sells shares in the capital of Manako at a fixed valuation, including but not limited to, a pre-money or post-money valuation (“Equity Financing”), on the initial closing of such financing, the SAFE will automatically convert into the number of shares of capital stock of Manako (having the identical rights, privileges, preferences, seniority, liquidation multiple and restrictions as the shares of capital stock of Manako issued to investors in such Equity Financing) equal to the Safe Amount divided by the Conversion Price. The Conversion Price is set as either (1) the price per share equal to (i) $40,000,000 divided by (ii) the number of shares of Manako outstanding immediately prior to such financing on a fully-diluted basis or (2) (i) the lowest price per share of shares issued in such financing multiplied by (ii) 0.8, whichever calculation results in the greater number of shares.
 
The SAFE also contains such other customary provisions and mutual representation and warranties, as a customary for transactions of this type.
 
In connection with the SAFE, the Company and Manako also entered into a SAFE Side Letter Agreement, dated as of May 28, 2026 (the “SAFE Side Letter”), pursuant to which Manako granted to the Company several investor rights, including, but not limited to, certain information rights, right to receive prior notice with respect to any material change to identified key persons, and a right the right to subscribe for the Company’s pro rata share of shares of Manako being issued in the next Equity Financing, which pro rata right is calculated as set forth in the SAFE Side Letter.
 
The foregoing descriptions of the TLDA, Lock-Up Agreement, SAFE, SAFE Side Letter and Warrants, do not purport to be complete and are qualified in their entirety by reference to the full text of such documents, forms of which are filed as Exhibits 10.1, 10.2, 10.3, 10.4 and 4.1, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
 
3.02: Unregistered Sales of Equity Securities
 
The matters described in Item 1.01 of this Current Report on Form 8-K related to the Warrants are incorporated herein by reference.
 
In connection with the issuance of the Warrants described in Item 1.01, the Company relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transactions not involving a public offering.
 
This report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
 
7.01: Regulation FD Disclosure
 
On June 1, 2026, the Company issued a press release announcing the TLDA and SAFE investment. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated by reference herein.
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.
 
2

 
9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit No.
Description
4.1 Form of Warrant
10.1*
Technology License and Distribution Agreement, dated May 28, 2026, by and between the Company and Manako Labs Ltd.
10.2 Lock-Up Agreement, dated May 29, 2026, by and between the Company and Manako Labs Ltd.
10.3 Simple Agreement for Future Equity, dated May 28, 2026, by and between the Company and Manako Labs Ltd.
10.4* SAFE Side Letter Agreement, dated May 28, 2026, by and between the Company and Manako Labs Ltd.
99.1
Press Release of TaoWeave, Inc. dated June 1, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
* Certain portions of this exhibit have been redacted in accordance with Item 601(a)(5) and Item 601(b)(10)(iv) of Regulation S-K under the Securities Act. The registrant hereby agrees to furnish an unredacted copy of the exhibit to the SEC upon its request.
 
3

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
TAOWEAVE, INC.
June 3, 2025
By:
/s/ Peter Holst
Peter Holst
President & CEO
 
 
4
 

 

EXHIBIT 99.1

 

TAOWEAVE EXPANDS INTO PHYSICAL AI WITH INVESTMENT IN MANAKO LABS AND NORTH AMERICAN COMMERCIALIZATION RIGHTS

 

Establishes TaoWeaves First Operating Investment, Combining Equity Ownership, Commercialization Rights and Revenue Participation

 

DENVER, CO and LONDON, UK, June 1, 2026 — TaoWeave, Inc. (Nasdaq: TWAV) today announced its entry into the emerging Physical AI market through an investment in Manako Labs Ltd. and a preferred North American commercialization partnership.

 

The transaction marks TaoWeave’s first operating investment in artificial intelligence and expands TaoWeave’s strategy beyond digital asset treasury activities into enterprise AI deployment, commercialization, and recurring operating revenue.

 

Under the agreements, TaoWeave has invested $1 million in Manako and will earn revenue generated through licensing agreements.

 

“Our experience in the Bittensor ecosystem has given us a unique perspective on where artificial intelligence is creating real world value”, said Pete Holst, Chief Executive Officer of TaoWeave. “Physical AI is one of the most compelling opportunities emerging in artificial intelligence. As we spent time with the Manako team, it became clear that they had built something special. The quality of the team, strength of the platform, and the size of the opportunity made this a natural partnership for TaoWeave.”

 

As AI moves beyond digital workflows and into factories, warehouses, transportation networks, and other operational environments, organizations need systems that can build an accurate understanding of the physical world and translate that understanding into action.

 

Most organizations already possess extensive camera infrastructure across their operations. Yet, the majority of data generated by those systems remains unused. Manako converts this data into actionable intelligence used to monitor activity, identify emerging issues, and automate operational workflows using hardware already deployed across customer facilities.

 

Industry research estimates the Physical AI market was valued at approximately $82 billion in 2025 and could approach $1 trillion by 2033.

 

“TaoWeave understood very early that the future of AI extends beyond software and into real-world businesses,” said Max Sebti, Chief Executive Officer of Manako Labs. “That’s why Physical AI is becoming such an important part of enterprise AI. TaoWeave is an ideal commercialization partner to accelerate our expansion in North America, the world’s largest market for AI adoption.”

 

TaoWeave entered the Bittensor ecosystem to gain exposure to emerging AI technologies. The company subsequently identified a larger opportunity in owning, operating, and commercializing AI businesses. Manako operates Score (Subnet 44), one of the leading subnets within the Bittensor network. This investment marks TaoWeave’s first operating platform investment and the beginning of its expansion into AI commercialization.

 

Manako recently won first place at Start In Block, the flagship startup competition held during Paris Blockchain Week, where it was selected from more than 1,000 applicants worldwide.

 

In addition to commercialization rights and revenue participation, the agreement provides a pathway for TaoWeave to develop proprietary AI infrastructure within the broader Bittensor ecosystem. Together, these capabilities position the Company to participate in the creation, commercialization, and operation of Physical AI technologies as adoption accelerates across enterprise markets.

 

ABOUT TAOWEAVE

 

TaoWeave, Inc. (Nasdaq: TWAV) is building an artificial intelligence commercialization platform focused on identifying, investing in, and scaling emerging AI technologies. Through strategic investments, operating partnerships, and participation in the Bittensor ecosystem, TaoWeave seeks to accelerate adoption of next generation AI applications while creating long term shareholder value.

 

About Manako Labs Ltd.

 

Manako Labs is a Physical AI company building a Business World Model. The company’s platform transforms existing camera networks into a real-time understanding of operations. The platform enables organizations to detect issues, coordinate responses, and improve decision-making across industrial, logistics, retail, and infrastructure environments. Manako deploys on existing infrastructure and integrates with operational systems without requiring new hardware or specialist AI expertise.

 

1

 

Forward-Looking Statements and Risk Factors

 

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that TaoWeave assumes, plans, expects, believes, intends, projects, estimates, or anticipates (and other similar expressions) will, should, or may occur in the future are forward-looking statements. TaoWeave’s actual results may differ materially from its expectations, estimates, and projections, and consequently, you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to TaoWeave’s commercialization partnership with Manako and anticipated revenue opportunities, customer adoption and the market opportunity of Physical AI technologies, and future development of proprietary AI infrastructure and participation in the Bittensor ecosystem. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. Digital assets are highly volatile, and actual results may differ materially due to price fluctuations, regulatory changes, technological risks, or other factors described in the Company’s SEC filings. The Company’s concentration in TAO tokens represents significant market risk. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2025, the Company’s Form 10-Q filed on May 15, 2026, and in other filings made by the Company with the SEC from time to time. Any of these factors could cause TaoWeave’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company can give no assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

 

Investor Relations Contact

 

David Clark

 

investors@taoweave.com

 

(213) 683-8863 ext. 5

 

 

2

FAQ

What did TaoWeave (OBLG) announce about its partnership with Manako Labs?

TaoWeave announced a Technology License and Distribution Agreement with Manako Labs, giving it rights to commercialize Manako’s Physical AI Score platform in North America and share in related revenues. The deal marks TaoWeave’s first operating investment in artificial intelligence.

How much is TaoWeave (OBLG) investing in Manako Labs and in what form?

TaoWeave is investing $1,000,000 in Manako Labs through a Simple Agreement for Future Equity, or SAFE. The SAFE converts into Manako shares in a future equity financing using a defined conversion price formula tied to a $40 million valuation or a discount to financing prices.

What warrant package did TaoWeave (OBLG) grant to Manako Labs?

TaoWeave will issue Manako warrants to buy up to 300,000 common shares in three tranches at exercise prices of $3.41, $4.50, and $5.50 per share. Exercises are capped by a 9.99% beneficial ownership limitation to manage Manako’s post-exercise stake.

How will TaoWeave (OBLG) and Manako share revenue from the Physical AI platform?

Under the agreements, TaoWeave must pay Manako a share of net revenue from TaoWeave-sourced platform customers. When Manako closes deals sourced by TaoWeave, TaoWeave earns referral fees, and for Manako-led deals in the territory, TaoWeave can receive market development fees based on contract value.

What lock-up and trading restrictions apply to the TaoWeave (OBLG) warrants issued to Manako?

The warrants are locked up for at least six months after issuance or until warrant share registration becomes effective, whichever is later. Afterward, a 24‑month period applies with daily volume caps, a 120% exercise-price floor, notice requirements, and specific carve‑outs for certain transfers and Rule 10b5‑1 sales.

How does this deal change TaoWeave’s (OBLG) business strategy?

TaoWeave states the Manako transaction is its first operating AI investment and expands its strategy beyond digital asset treasury activities. The company aims to build an AI commercialization platform focused on identifying, investing in, and scaling emerging AI technologies with recurring operating revenue.

Filing Exhibits & Attachments

10 documents